Filing Details
- Accession Number:
- 0001209191-23-056768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-28 16:10:01
- Reporting Period:
- 2023-11-27
- Accepted Time:
- 2023-11-28 16:10:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1845459 | Nkgen Biotech Inc. | NKGN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1991119 | Y. Paul Song | Nkgen Biotech, Inc. 3001 Daimler Street Santa Ana CA 92705 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-27 | 103 | $2.91 | 170,561 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-11-27 | 140 | $2.85 | 170,701 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
